Atlas Trials

Levosimendan Versus Dobutamine in Shock Patients

Clinical trial NCT00093301 · UNKNOWN

Trial details

NCT number
NCT00093301
Sponsor
Wentworth Area Health Services
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cardiogenic ShockSeptic Shock
Start date
2004-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.